Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Oral vs Sublingual 17-Beta-Estradiol in Transgender Women
NCT05428215Phase 4Terminated
- Sponsor
- MaineHealth
- Start
- Dec 2022
- Primary completion
- Jul 2023
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of estradiol in gender dysphoria (GD), sponsored by MaineHealth. Started Dec 2022; status: terminated.
02
Drugs
estradiol
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on NCT05428215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05428215.